Clinical Study

The Effect of Perioperative Topical Ketorolac 0.5% on Macular Thickness after Uneventful Phacoemulsification

Figure 2

Changes in parafoveal thickness (ParaFT) and perifoveal thickness (PeriFT) in group 1 (ketorolac/steroid group) and group 2 (steroid group). The ParaFT and PeriFT were significantly lower in group 1 at the first and second months postoperatively (ParaFT , ; PeriFT , , resp.).